TERN-701

all catalysts(0)

nothing on the calendar yet

News(2)

• J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
  New data suggest Imaavy could be an effective treatment for autoimmune anemia. Elsewhere, Enliven detailed data for a Merck leukemia rival and MBX hyperparathyroidism drug hit its goal.
  biopharma_dive · 2mo ago
• Merck still sees ‘compelling’ outlook for Terns leukemia drug
  Despite updated study data that suggest Terns’ treatment may be less differentiated, company executives claimed Thursday that it still could be an important step forward in care.
  biopharma_dive · 3mo ago